The Discounted Cash Flow (DCF) valuation of Insmed Inc (INSM) is (316.30) USD. With the latest stock price at 130.66 USD, the upside of Insmed Inc based on DCF is -342.1%.
Based on the latest price of 130.66 USD and our DCF valuation, Insmed Inc (INSM) is a sell. selling INSM stocks now will result in a potential gain of 342.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.5% - 8.1% | 6.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,687.80) - (179.71) | (316.30) |
| Upside | -1391.7% - -237.5% | -342.1% |